News

Saab's Gripen E/F Selected as Future Fighter for Thailand

Saab's Gripen E/F Selected as Future Fighter for Thailand

Royal Thai Air Force Selects Saab Gripen E/F for Future Operations

The Royal Thai Air Force has officially chosen the Saab Gripen E/F as its new multi-role fighter, marking a significant step forward in modernizing its air capabilities. This decision comes as part of an ongoing effort to enhance national defense and ensure strategic independence.

Next Steps in the Procurement Process

Despite this selection, it is important to note that at this stage, Saab has yet to finalize a contract or receive an official order. The process moving forward will involve detailed discussions between Saab and the Swedish Defence Materiel Administration (FMV) to establish the framework for procurement.

Long-Term Benefits and Job Creation

Saab’s proposal not only includes the delivery of Gripen E/F fighter aircraft and necessary equipment but also promises a long-term offset package. This aspect is particularly crucial as it aims to bolster Thailand's national security while simultaneously generating new employment opportunities. The precise details regarding this offset package will be elaborated upon as negotiations proceed.

Micael Johansson's Remarks

Micael Johansson, the President and CEO of Saab, expressed enthusiasm regarding the selection. He remarked, "We welcome the Royal Thai Air Force's selection of Gripen E/F as its future fighter and look forward to the next steps in this procurement process. Gripen E/F is the best solution to provide Thailand with independent airpower for the future, which will contribute significantly to the nation's safety and security." This sentiment highlights Saab's commitment to supporting Thailand's defense objectives, ensuring a robust air force capable of safeguarding the nation.

Gripen C/D Transition

The Royal Thai Air Force has had a longstanding relationship with Saab, having operated the Gripen C/D models since 2011. The transition to the more advanced Gripen E/F represents a logical progression in enhancing air combat capabilities and adapting to modern warfare requirements.

About Saab

Saab is a leading defense and security company dedicated to assisting nations in protecting their citizens and societies. With a workforce of approximately 25,000 talented individuals, the company is recognized for pushing the limits of technological innovation to create a safer, more sustainable world. Saab is involved in designing, manufacturing, and maintaining advanced systems in various sectors including aeronautics, weaponry, command and control, sensors, and underwater systems.

Global Presence

Headquartered in Sweden, Saab operates major facilities around the globe, contributing to the defense capabilities of numerous nations. The selection of the Gripen E/F underscores the significance of multinational partnerships in enhancing defense readiness and national security.

Frequently Asked Questions

What fighter aircraft has the Royal Thai Air Force selected?

The Royal Thai Air Force has selected the Saab Gripen E/F as its future multi-role fighter.

When did the Royal Thai Air Force start operating Gripen aircraft?

The Royal Thai Air Force has been operating the Gripen C/D models since 2011.

What are the benefits of the Gripen E/F for Thailand?

The Gripen E/F will enhance Thailand's airpower and contribute to national security and strategic independence while creating new job opportunities.

Who is the CEO of Saab?

Micael Johansson is the current President and CEO of Saab.

Where is Saab headquartered?

Saab is headquartered in Sweden and has a global operational footprint, serving various nations' defense needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading